Literature DB >> 22938842

Antidepressive treatment with monoamine oxidase inhibitors and the occurrence of intraoperative hemodynamic events: a retrospective observational cohort study.

Ingrid M M van Haelst1, Wilton A van Klei, Hieronymus J Doodeman, Cor J Kalkman, Toine C G Egberts.   

Abstract

OBJECTIVE: To investigate the occurrence of intraoperative hemodynamic events when antidepressive treatment with monoamine oxidase inhibitors (MAOIs) was continued during anesthesia.
METHOD: A retrospective observational cohort study was conducted among patients who were admitted for elective surgery requiring anesthesia in 8 Dutch hospitals (2004-2010). The index group included current users of irreversible (tranylcypromine) and reversible (moclobemide) MAOIs. The reference group included a sample of nonusers matched to the index group on hospital, type and period of surgery, and type of anesthesia (ratio 1:3). The outcome of interest was the occurrence of the following intraoperative hemodynamic events: hypotension or hypertension and tachycardia or bradycardia.
RESULTS: Approximately 280,000 surgical procedures were performed in the participating hospitals in the total observational period of 33 years. The index group included 26 and 25 users of tranylcypromine and moclobemide, respectively. The reference groups included 149 nonusers. Intraoperative hypotension occurred less frequently in users of tranylcypromine (46%) than in nonusers (73%) (P = .01). The occurrence of hypertension, bradycardia, and tachycardia during anesthesia was not different between users of tranylcypromine (27%, 50%, and 12%, respectively) and those in the reference group (35%, 61%, and 26%, respectively). The occurrence of hypotension, hypertension, bradycardia, and tachycardia was not different between users of moclobemide and the reference group.
CONCLUSIONS: Severe adverse hemodynamic events, such as hypertension and tachycardia, did not occur more frequently in users of both the irreversible MAOI tranylcypromine and the reversible MAO-A inhibitor moclobemide compared to nonusers. These findings suggest that there is no longer much justification to discontinue these MAOIs before surgery, with the considerable risk of compromising patients' psychiatric status. © Copyright 2012 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22938842     DOI: 10.4088/JCP.11m07607

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

Review 1.  Monoamine oxidases as sources of oxidants in the heart.

Authors:  Nina Kaludercic; Jeanne Mialet-Perez; Nazareno Paolocci; Angelo Parini; Fabio Di Lisa
Journal:  J Mol Cell Cardiol       Date:  2014-01-09       Impact factor: 5.000

2.  Intraoperative hypotension and delirium after on-pump cardiac surgery.

Authors:  E M Wesselink; T H Kappen; W A van Klei; J M Dieleman; D van Dijk; A J C Slooter
Journal:  Br J Anaesth       Date:  2015-07-25       Impact factor: 9.166

3.  Parkinson's Disease and Its Management: Part 3: Nondopaminergic and Nonpharmacological Treatment Options.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-10

4.  Perioperative Considerations for Patients With Major Depressive Disorder Undergoing Surgery.

Authors:  Edwin N Aroke; Alexis N Robinson; Bryan A Wilbanks
Journal:  J Perianesth Nurs       Date:  2020-01-16       Impact factor: 1.084

5.  Concurrent use of ketamine and monoamine oxidase inhibitors in the treatment of depression: A letter to the editor.

Authors:  R B Katz; M Toprak; S T Wilkinson; G Sanacora; R Ostroff
Journal:  Gen Hosp Psychiatry       Date:  2018-05-22       Impact factor: 3.238

Review 6.  Monoamine Oxidase-Related Vascular Oxidative Stress in Diseases Associated with Inflammatory Burden.

Authors:  Adrian Sturza; Călin M Popoiu; Mihaela Ionică; Oana M Duicu; Sorin Olariu; Danina M Muntean; Eugen S Boia
Journal:  Oxid Med Cell Longev       Date:  2019-04-15       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.